Total planned funding: $214,009,492
Allocations
Countries/Regions
India | $214,009,492 |
Organizational Types
Unknown | $84,429,824 |
NGO | $65,792,046 |
Own Agency | $31,335,919 |
University | $18,791,895 |
Multi-lateral Agency | $4,166,808 |
Implementing Agency | $3,100,000 |
Private Contractor | $2,409,000 |
FBO | $1,600,000 |
Host Country Government Agency | $1,349,400 |
Other USG Agency | $1,034,600 |
Program Areas
Governance and Systems | $87,497,976 |
Prevention | $51,355,446 |
Care | $26,962,371 |
Management and Operations | $22,762,324 |
Treatment | $10,714,298 |
Testing | $10,289,285 |
Budget Codes
OHSS: Health Systems Strengthening | $50,477,231 |
HVSI: Strategic Information | $29,927,433 |
HVOP: Sexual Prevention: Other Sexual Prevention | $27,934,146 |
HVMS: Management and Operations | $22,762,324 |
HBHC: Care: Adult Care and Support | $16,550,999 |
HVCT: Testing: HIV Testing and Counseling | $10,289,285 |
HTXS: Treatment: Adult Treatment | $10,182,803 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $8,340,645 |
HLAB: Laboratory Infrastructure | $7,093,312 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $6,940,504 |
HKID: Care: Orphans and Vulnerable Children | $5,652,421 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,356,472 |
HVTB: Care: TB/HIV | $4,125,628 |
HMBL: Biomedical Prevention: Blood Safety | $2,773,679 |
PDCS: Care: Pediatric Care and Support | $633,323 |
PDTX: Treatment: Pediatric Treatment | $508,018 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$82,757,846
Countries/Regions
FHI 360:
$23,463,928
Countries/Regions
USG Aggregated Agencies:
$15,691,183
Countries/Regions
Voluntary Health Services:
$12,430,000
Countries/Regions